In this on-demand webinar, Indrani Sarkar, Associate Vice President, Assay Development & Screening at Aragen Life Sciences, explores the biological and technical considerations critical to successful GPCR-targeted drug discovery. The session highlights how a deeper understanding of receptor biology can enable the design of robust, predictive, and fit-for-purpose screening assays.
Watch now to learn how to navigate challenges such as receptor heterogeneity, ligand bias, signalling pathway complexity, cellular context, and GPCR deorphanization, while implementing assay strategies that improve screening outcomes and support informed decision-making in drug discovery.
Understand GPCR biology and its impact on assay design.
Learn strategies to address signalling complexity, ligand bias, and cellular context.
Discover best practices for optimising GPCR screening workflows.
Explore approaches to tackle GPCR deorphanization challenges
Indrani Sarkar
Associate Vice President – Assay Development and Screening, Aragen Life Sciences
